CPHI Americas 2026 to focus on regulatory shifts, AI and biotech innovation
· Source: manufacturingchemist.com
In short
CPHI Americas 2026 will center on evolving regulatory frameworks, artificial intelligence, supply chain resilience, and biotech innovation. The conference agenda includes sessions on navigating FDA changes, embedding AI across drug discovery, and building resilient pharma supply chains with leaders from Bayer, UCB, and the US Secret Service. The event aims to provide practical insights for pharmaceutical manufacturers and biotech companies facing industry-wide challenges.
Read Original Article — Read the full article on the publisher’s site.
In the issue of week 18, 2026: Agentic AI and Physical Automation Drive Supply Chain Breakthroughs
Tags: pharmaceutical, supply chain, AI, biotech, regulatory, drug discovery